TNFRSF1B and autoimmune disease: This study suggests that targeting of tmTNF–TNFR2 interaction may represent a novel strategy in the treatment of autoimmune diseases, especially in those patients that do not to respond to conventional anti-TNF treatment, by mobilization of TNFR2+ Tregs (84).